论文信息 - Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma - 字舞流文

Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma

K. Kelly | A. Lassman | K. Papadopoulos | M. Khasraw | P. Ansell | Mark G. Anderson | B. Carneiro | Y. Chae | H. Gan | J. Patel | J. Strickler | R. Merrell | S. Waqar | Randy R. Robinson | E. Reilly | H. Atluri | C. Bestvina | Rachel W. Li | K. Patel | J. Jin | E. Shacham-Shmueli | Kevin Huang | G. Morrison-Thiele | Martha R Neagu Aristide | Gladys Morrison-Thiele